Labcorp (NYSE: LH) sets July 30, 2026 Q2 earnings webcast
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Labcorp Holdings Inc. will release its financial results for the second quarter of 2026 before the market opens on July 30, 2026. The company will host a webcast at 9:00 a.m. ET the same day to discuss the results.
The earnings press release and detailed financial information will be posted in the “News & Events” section of Labcorp’s investor relations website, where investors can also access the live webcast link. A replay of the webcast will be available on the same site about two hours after the live event and will remain accessible for one year.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Earnings release date: July 30, 2026
Webcast time: 9:00 a.m. ET
Webcast replay availability: One year
+4 more
7 metrics
Earnings release date
July 30, 2026
Q2 2026 financial results before market opens
Webcast time
9:00 a.m. ET
Q2 2026 earnings discussion on July 30, 2026
Webcast replay availability
One year
Replay posted about two hours after live event
Employees
Nearly 71,000 employees
Global workforce serving clients in about 100 countries
Global reach
Approximately 100 countries
Countries where clients are served
FDA approvals supported
More than 85%
Share of new drugs and therapeutic products approved by FDA in 2025
Tests performed
More than 750 million tests
Annual patient tests performed worldwide
Key Terms
webcast, earnings press release, investor relations website, Inline XBRL, +1 more
5 terms
webcast financial
"will host a webcast beginning at 9:00 a.m. ET that day"
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.
earnings press release financial
"The earnings press release and accompanying financial information will be posted"
investor relations website financial
"posted on the “News & Events” section of the Labcorp Investor Relations website"
An investor relations website is a company's online page where it shares important information with current and potential investors, like financial results, company news, and future plans. It’s like a company’s official report card that helps people understand how the business is doing and decide whether to invest or stay informed.
Inline XBRL regulatory
"Exhibit 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
emerging growth company regulatory
"Emerging growth company Labcorp Holdings Inc. (NYSE: LH)"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
(Date of earliest event reported)
(Exact Name of Registrant as Specified in its Charter)
| (State or other jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| , | ||||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
(Registrant’s telephone number including area code) 336 -229-1127
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Exchange Act.
| Title of each class | Trading Symbol | Name of exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01. | Regulation FD Disclosure. | ||||
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on June 30, 2026 that it will release its financial results for the second quarter of 2026 before the market opens on Thursday, July 30, 2026, and will host a conference call and webcast beginning at 9:00 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
A copy of the press release dated June 30, 2026 is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
| Item 9.01. | Financial Statements and Exhibits. | |||||||
| Exhibit | Exhibit Name | |||||||
| Exhibit 99.1 | Press release dated June 30, 2026 issued by Labcorp Holdings Inc. | |||||||
| Exhibit 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LABCORP HOLDINGS INC.
Registrant
| Date: June 30, 2026 | By: | /s/ KATHRYN W. KYLE | ||||||
| Kathryn W. Kyle | ||||||||
| Executive Vice President, Chief Legal Officer and Corporate Secretary | ||||||||
FOR IMMEDIATE RELEASE
| Media | Investor Relations | |||||||
| Racquel White | Dewey Steadman | |||||||
| Media@Labcorp.com | Investor@Labcorp.com | |||||||
Labcorp to Announce Second Quarter Financial Results on July 30, 2026
BURLINGTON, N.C., (June 30, 2026) – Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on Thursday, July 30, 2026. The company will host a webcast beginning at 9:00 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the “News & Events” section of the Labcorp Investor Relations website at https://ir.labcorp.com. A link to the earnings webcast will also be available on the investor relations website.
A replay of the webcast will be available on the “News & Events” section of the investor relations website approximately two hours after the conclusion of the live event and will be available for one year.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025, and performed more than 750 million tests for patients around the world. Learn more at https://www.labcorp.com/.
FAQ
When will Labcorp (LH) report its Q2 2026 financial results?
Labcorp will release its Q2 2026 financial results on July 30, 2026 before the market opens. The company will also host a webcast that morning to discuss the results and provide additional context for investors.
What time is Labcorp’s Q2 2026 earnings webcast on July 30, 2026?
The Q2 2026 earnings webcast begins at 9:00 a.m. ET on July 30, 2026. Investors can access the live webcast through the “News & Events” section of the Labcorp investor relations website.
Where can investors find Labcorp’s Q2 2026 earnings press release and materials?
The Q2 2026 earnings press release and financial information will be posted on the “News & Events” section of Labcorp’s investor relations website. A link to the live webcast will be available on the same page.
How long will the replay of Labcorp’s Q2 2026 earnings webcast be available?
A replay of Labcorp’s Q2 2026 earnings webcast will be available on the investor relations website about two hours after the live event. The replay will remain accessible for one year in the “News & Events” section.
What does Labcorp (LH) say about its global scale in this filing?
Labcorp notes it has nearly 71,000 employees serving clients in about 100 countries. The company supported more than 85% of new drugs and therapeutic products approved by the FDA in 2025 and performed over 750 million tests worldwide.
How can media and investors contact Labcorp regarding the Q2 2026 results?
Media inquiries can be sent to Media@Labcorp.com, and investor questions to Investor@Labcorp.com. The filing lists Racquel White for media relations and Dewey Steadman for investor relations as key contacts.